MS049 |
1502816-23-0 |
1502816-23-0 |
2-[8-Chloro-6-(4-chloro-phenyl)-1-Methyl-4H-3-oxa-2,5-diaza-benzo[e]azulen-4-yl]-acetaMide |
化合物BET BROMODOMAIN INHIBITOR |
1505453-59-7 |
N,N′-Bis-(4-thiazol-2-yl-benzyl)-ethane-1,2-diamine |
N,N′-Bis-(4-thiazol-2-yl-benzyl)-ethane-1,2-diamine |
1507370-40-2 |
N1,N2-Bis[[4-(2-pyridinyl)phenyl]methyl]- 1,2-ethanediamine |
化合物BC-1215 |
1507370-20-8 |
EGF816 |
EGF816 |
1508250-71-2 |
ETC-206 |
4-[6-[4-(4-吗啉基羰基)苯基]咪唑并[1,2-A]吡啶-3-基]苄腈 |
1464151-33-4 |
6-chloro-5-(4-(1-hydroxycyclobutyl)phenyl)-1H-indole-3-carboxylicacid |
PF-06409577 |
1467057-23-3 |
N-(5-(3-(7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide |
SM04690 |
1467093-03-3 |
Atglistatin |
ATGLISTATIN |
1469924-27-3 |
Pyridostatin TFA salt |
CS-2156 |
1472611-44-1 |
7ACC-2 |
7ACC-2 |
1472624-85-3 |
N-(4-ethylphenyl)-3-(hydroxymethyl)-N-isobutyl-4-((tetrahydro-2H-pyran-4-yl)methoxy)benzenesulfonamide |
GSK2981278 |
1474110-21-8 |
CAY10683 (SantacruzaMate A) |
HDAC抑制剂 |
1477949-42-0 |
UNC-0642 |
2-(4,4-二氟-1-哌啶基)-6-甲氧基-N-[1-异丙基-4-哌啶基]-7-[3-(1-吡咯烷基)丙氧基]-4-喹唑啉胺 |
1481677-78-4 |
2-(3-(Trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)acetohydrazide hydrochloride |
2-(3-(TRIFLUOROMETHYL)-5,6-DIHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL)ACETOHYDRAZIDE HYDROCHLORIDE |
1485732-85-1 |
HUHS015 |
HUHS015 |
1453097-13-6 |
GDC-0994 |
GDC-0994 |
1453848-26-4 |
PU-WS13 |
6-氨基-8-[(3,5-二氯苯基)硫基]-N-异丙基-9H-嘌呤-9-丙胺 |
1454619-14-7 |
LY-3009120 |
LY-3009120 |
1454682-72-4 |
SH-4-54 |
SH-4-54 |
1456632-40-8 |